Tumambiling, Aisa A.

HRN: 27-00-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFTRIAXONE 1G (VIAL)
11/06/2025
11/12/2025
IV
2g
Q24H
Acute Cholecystitis
Waiting Final Action 
11/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2025
11/12/2025
IVT
500 Mg
Q8H
Acute Cholecystitis
Waiting Final Action 
11/11/2025
CEFUROXIME 750MG (VIAL)
11/11/2025
11/18/2025
IV
750 Mg
Q8HRS
Acute Calculous Cholelithiasis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: